mTOR is a protein that is responsible for cell growth, proliferation, and survival. When mTOR is activated, it signals the cell to start making new proteins, which leads to an increase in cell size and mass. mTOR is also involved in regulating cellular metabolism and energy production.

In addition, mTOR plays a role in cancer by promoting cell growth and survival. When mTOR is overactive, it can lead to the development of cancerous tumors.

mTOR inhibitors have shown promise in the treatment of cancer, as they can help to stop cancer cells from growing and spreading. In addition, mTOR inhibitors have also been studied for their potential to treat other conditions, such as diabetes, obesity, and autoimmune diseases.

There are two types of mTOR inhibitors: rapamycin and everolimus. Rapamycin was the first mTOR inhibitor to be developed, and it is still the most widely used mTOR inhibitor. Everolimus is a newer mTOR inhibitor that is sometimes used in combination with rapamycin.

mTOR inhibitors are still being researched and more studies are needed to determine their safety and effectiveness. However, mTOR inhibitors hold promise as a potential treatment for a variety of conditions.

Books discussing mTOR

Experts discussing mTOR